Request for Covid-19 Impact Assessment of this Report
Sales, means the sales volume of Recombinant Antibody
Revenue, means the sales value of Recombinant Antibody
This report studies sales (consumption) of Recombinant Antibody in USA market, focuses on the top players, with sales, price, revenue and market share for each player, covering
A.G. Scientific, Inc. (US)
Abbott Diagnostics (US)
Agilent Technologies, Inc. (US)
BD Biosciences (US)
Beckman Coulter, Inc. (US)
bioMerieux (France)
Bio-Rad Laboratories, Inc. (US)
F. Hoffmann-La Roche Ltd. (Switzerland)
Gallus Immunotech, Inc. (Canada)
GE Healthcare (UK)
Lonza Biologics Ltd. (Switzerland)
Merck KGaA (Germany)
Meridian Life Science, Inc. (US)
PerkinElmer, Inc. (US)
Promega Corporation (US)
Qiagen N.V. (Netherlands)
R&D Systems (US)
SDIX, LLC (US)
Shimadzu Corporation (Japan)
Takara Bio, Inc. (Japan)
Thermo Fisher Scientific Inc. (US)
Wako Pure Chemical Industries Ltd. (Japan)
Waters Corp. (US)
Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into
Type I
Type II
Type III
Split by applications, this report focuses on sales, market share and growth rate of Recombinant Antibody in each application, can be divided into
Medical care
Experiment
Application 3
United States Recombinant Antibody Market Report 2016
1 Recombinant Antibody Overview
1.1 Product Overview and Scope of Recombinant Antibody
1.2 Classification of Recombinant Antibody
1.2.1 Type I
1.2.2 Type II
1.2.3 Type III
1.3 Application of Recombinant Antibody
1.3.1 Medical care
1.3.2 Experiment
1.3.3 Application 3
1.4 USA Market Size Sales (Value) and Revenue (Volume) of Recombinant Antibody (2011-2021)
1.4.1 USA Recombinant Antibody Sales and Growth Rate (2011-2021)
1.4.2 USA Recombinant Antibody Revenue and Growth Rate (2011-2021)
2 USA Recombinant Antibody Competition by Manufacturers
2.1 USA Recombinant Antibody Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 USA Recombinant Antibody Revenue and Share by Manufactures (2015 and 2016)
2.3 USA Recombinant Antibody Average Price by Manufactures (2015 and 2016)
2.4 Recombinant Antibody Market Competitive Situation and Trends
2.4.1 Recombinant Antibody Market Concentration Rate
2.4.2 Recombinant Antibody Market Share of Top 3 and Top 5 Manufacturers
2.4.3 Mergers & Acquisitions, Expansion
3 USA Recombinant Antibody Sales (Volume) and Revenue (Value) by Type (2011-2016)
3.1 USA Recombinant Antibody Sales and Market Share by Type (2011-2016)
3.2 USA Recombinant Antibody Revenue and Market Share by Type (2011-2016)
3.3 USA Recombinant Antibody Price by Type (2011-2016)
3.4 USA Recombinant Antibody Sales Growth Rate by Type (2011-2016)
4 USA Recombinant Antibody Sales (Volume) by Application (2011-2016)
4.1 USA Recombinant Antibody Sales and Market Share by Application (2011-2016)
4.2 USA Recombinant Antibody Sales Growth Rate by Application (2011-2016)
4.3 Market Drivers and Opportunities
5 USA Recombinant Antibody Manufacturers Profiles/Analysis
5.1 A.G. Scientific, Inc. (US)
5.1.1 Company Basic Information, Manufacturing Base and Competitors
5.1.2 Recombinant Antibody Product Type, Application and Specification
5.1.2.1 Type I
5.1.2.2 Type II
5.1.3 A.G. Scientific, Inc. (US) Recombinant Antibody Sales, Revenue, Price and Gross Margin (2011-2016)
5.1.4 Main Business/Business Overview
5.2 Abbott Diagnostics (US)
5.2.2 Recombinant Antibody Product Type, Application and Specification
5.2.2.1 Type I
5.2.2.2 Type II
5.2.3 Abbott Diagnostics (US) Recombinant Antibody Sales, Revenue, Price and Gross Margin (2011-2016)
5.2.4 Main Business/Business Overview
5.3 Agilent Technologies, Inc. (US)
5.3.2 Recombinant Antibody Product Type, Application and Specification
5.3.2.1 Type I
5.3.2.2 Type II
5.3.3 Agilent Technologies, Inc. (US) Recombinant Antibody Sales, Revenue, Price and Gross Margin (2011-2016)
5.3.4 Main Business/Business Overview
5.4 BD Biosciences (US)
5.4.2 Recombinant Antibody Product Type, Application and Specification
5.4.2.1 Type I
5.4.2.2 Type II
5.4.3 BD Biosciences (US) Recombinant Antibody Sales, Revenue, Price and Gross Margin (2011-2016)
5.4.4 Main Business/Business Overview
5.5 Beckman Coulter, Inc. (US)
5.5.2 Recombinant Antibody Product Type, Application and Specification
5.5.2.1 Type I
5.5.2.2 Type II
5.5.3 Beckman Coulter, Inc. (US) Recombinant Antibody Sales, Revenue, Price and Gross Margin (2011-2016)
5.5.4 Main Business/Business Overview
5.6 bioMerieux (France)
5.6.2 Recombinant Antibody Product Type, Application and Specification
5.6.2.1 Type I
5.6.2.2 Type II
5.6.3 bioMerieux (France) Recombinant Antibody Sales, Revenue, Price and Gross Margin (2011-2016)
5.6.4 Main Business/Business Overview
5.7 Bio-Rad Laboratories, Inc. (US)
5.7.2 Recombinant Antibody Product Type, Application and Specification
5.7.2.1 Type I
5.7.2.2 Type II
5.7.3 Bio-Rad Laboratories, Inc. (US) Recombinant Antibody Sales, Revenue, Price and Gross Margin (2011-2016)
5.7.4 Main Business/Business Overview
5.8 F. Hoffmann-La Roche Ltd. (Switzerland)
5.8.2 Recombinant Antibody Product Type, Application and Specification
5.8.2.1 Type I
5.8.2.2 Type II
5.8.3 F. Hoffmann-La Roche Ltd. (Switzerland) Recombinant Antibody Sales, Revenue, Price and Gross Margin (2011-2016)
5.8.4 Main Business/Business Overview
5.9 Gallus Immunotech, Inc. (Canada)
5.9.2 Recombinant Antibody Product Type, Application and Specification
5.9.2.1 Type I
5.9.2.2 Type II
5.9.3 Gallus Immunotech, Inc. (Canada) Recombinant Antibody Sales, Revenue, Price and Gross Margin (2011-2016)
5.9.4 Main Business/Business Overview
5.10 GE Healthcare (UK)
5.10.2 Recombinant Antibody Product Type, Application and Specification
5.10.2.1 Type I
5.10.2.2 Type II
5.10.3 GE Healthcare (UK) Recombinant Antibody Sales, Revenue, Price and Gross Margin (2011-2016)
5.10.4 Main Business/Business Overview
5.11 Lonza Biologics Ltd. (Switzerland)
5.12 Merck KGaA (Germany)
5.13 Meridian Life Science, Inc. (US)
5.14 PerkinElmer, Inc. (US)
5.15 Promega Corporation (US)
5.16 Qiagen N.V. (Netherlands)
5.17 R&D Systems (US)
5.18 SDIX, LLC (US)
5.19 Shimadzu Corporation (Japan)
5.20 Takara Bio, Inc. (Japan)
5.21 Thermo Fisher Scientific Inc. (US)
5.22 Wako Pure Chemical Industries Ltd. (Japan)
5.23 Waters Corp. (US)
6 Recombinant Antibody Manufacturing Cost Analysis
6.1 Recombinant Antibody Key Raw Materials Analysis
6.1.1 Key Raw Materials
6.1.2 Price Trend of Key Raw Materials
6.1.3 Key Suppliers of Raw Materials
6.1.4 Market Concentration Rate of Raw Materials
6.2 Proportion of Manufacturing Cost Structure
6.2.1 Raw Materials
6.2.2 Labor Cost
6.2.3 Manufacturing Expenses
6.3 Manufacturing Process Analysis of Recombinant Antibody
7 Industrial Chain, Sourcing Strategy and Downstream Buyers
7.1 Recombinant Antibody Industrial Chain Analysis
7.2 Upstream Raw Materials Sourcing
7.3 Raw Materials Sources of Recombinant Antibody Major Manufacturers in 2015
7.4 Downstream Buyers
8 Marketing Strategy Analysis, Distributors/Traders
8.1 Marketing Channel
8.1.1 Direct Marketing
8.1.2 Indirect Marketing
8.1.3 Marketing Channel Development Trend
8.2 Market Positioning
8.2.1 Pricing Strategy
8.2.2 Brand Strategy
8.2.3 Target Client
8.3 Distributors/Traders List
9 Market Effect Factors Analysis
9.1 Technology Progress/Risk
9.1.1 Substitutes Threat
9.1.2 Technology Progress in Related Industry
9.2 Consumer Needs/Customer Preference Change
9.3 Economic/Political Environmental Change
10 USA Recombinant Antibody Market Forecast (2016-2021)
10.1 USA Recombinant Antibody Sales, Revenue Forecast (2016-2021)
10.2 USA Recombinant Antibody Sales Forecast by Type (2016-2021)
10.3 USA Recombinant Antibody Sales Forecast by Application (2016-2021)
10.4 Recombinant Antibody Price Forecast (2016-2021)
11 Research Findings and Conclusion
12 Appendix
Author List
Disclosure Section
Research Methodology
Data Source
Disclaimer
Figure Picture of Recombinant Antibody
Table Classification of Recombinant Antibody
Figure USA Sales Market Share of Recombinant Antibody by Type in 2015
Table Application of Recombinant Antibody
Figure USA Sales Market Share of Recombinant Antibody by Application in 2015
Figure Medical care Examples
Figure Experiment Examples
Figure USA Recombinant Antibody Sales and Growth Rate (2011-2021)
Figure USA Recombinant Antibody Revenue and Growth Rate (2011-2021)
Table USA Recombinant Antibody Sales of Key Manufacturers (2015 and 2016)
Table USA Recombinant Antibody Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Recombinant Antibody Sales Share by Manufacturers
Figure 2016 Recombinant Antibody Sales Share by Manufacturers
Table USA Recombinant Antibody Revenue by Manufacturers (2015 and 2016)
Table USA Recombinant Antibody Revenue Share by Manufacturers (2015 and 2016)
Table 2015 USA Recombinant Antibody Revenue Share by Manufacturers
Table 2016 USA Recombinant Antibody Revenue Share by Manufacturers
Table USA Market Recombinant Antibody Average Price of Key Manufacturers (2015 and 2016)
Figure USA Market Recombinant Antibody Average Price of Key Manufacturers in 2015
Figure Recombinant Antibody Market Share of Top 3 Manufacturers
Figure Recombinant Antibody Market Share of Top 5 Manufacturers
Table USA Recombinant Antibody Sales by Type (2011-2016)
Table USA Recombinant Antibody Sales Share by Type (2011-2016)
Figure USA Recombinant Antibody Sales Market Share by Type in 2015
Table USA Recombinant Antibody Revenue and Market Share by Type (2011-2016)
Table USA Recombinant Antibody Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Recombinant Antibody by Type (2011-2016)
Table USA Recombinant Antibody Price by Type (2011-2016)
Figure USA Recombinant Antibody Sales Growth Rate by Type (2011-2016)
Table USA Recombinant Antibody Sales by Application (2011-2016)
Table USA Recombinant Antibody Sales Market Share by Application (2011-2016)
Figure USA Recombinant Antibody Sales Market Share by Application in 2015
Table USA Recombinant Antibody Sales Growth Rate by Application (2011-2016)
Figure USA Recombinant Antibody Sales Growth Rate by Application (2011-2016)
Table A.G. Scientific, Inc. (US) Basic Information List
Table A.G. Scientific, Inc. (US) Recombinant Antibody Sales, Revenue, Price and Gross Margin (2011-2016)
Figure A.G. Scientific, Inc. (US) Recombinant Antibody Sales Market Share (2011-2016)
Table Abbott Diagnostics (US) Basic Information List
Table Abbott Diagnostics (US) Recombinant Antibody Sales, Revenue, Price and Gross Margin (2011-2016)
Table Abbott Diagnostics (US) Recombinant Antibody Sales Market Share (2011-2016)
Table Agilent Technologies, Inc. (US) Basic Information List
Table Agilent Technologies, Inc. (US) Recombinant Antibody Sales, Revenue, Price and Gross Margin (2011-2016)
Table Agilent Technologies, Inc. (US) Recombinant Antibody Sales Market Share (2011-2016)
Table BD Biosciences (US) Basic Information List
Table BD Biosciences (US) Recombinant Antibody Sales, Revenue, Price and Gross Margin (2011-2016)
Table BD Biosciences (US) Recombinant Antibody Sales Market Share (2011-2016)
Table Beckman Coulter, Inc. (US) Basic Information List
Table Beckman Coulter, Inc. (US) Recombinant Antibody Sales, Revenue, Price and Gross Margin (2011-2016)
Table Beckman Coulter, Inc. (US) Recombinant Antibody Sales Market Share (2011-2016)
Table bioMerieux (France) Basic Information List
Table bioMerieux (France) Recombinant Antibody Sales, Revenue, Price and Gross Margin (2011-2016)
Table bioMerieux (France) Recombinant Antibody Sales Market Share (2011-2016)
Table Bio-Rad Laboratories, Inc. (US) Basic Information List
Table Bio-Rad Laboratories, Inc. (US) Recombinant Antibody Sales, Revenue, Price and Gross Margin (2011-2016)
Table Bio-Rad Laboratories, Inc. (US) Recombinant Antibody Sales Market Share (2011-2016)
Table F. Hoffmann-La Roche Ltd. (Switzerland) Basic Information List
Table F. Hoffmann-La Roche Ltd. (Switzerland) Recombinant Antibody Sales, Revenue, Price and Gross Margin (2011-2016)
Table F. Hoffmann-La Roche Ltd. (Switzerland) Recombinant Antibody Sales Market Share (2011-2016)
Table Gallus Immunotech, Inc. (Canada) Basic Information List
Table Gallus Immunotech, Inc. (Canada) Recombinant Antibody Sales, Revenue, Price and Gross Margin (2011-2016)
Table Gallus Immunotech, Inc. (Canada) Recombinant Antibody Sales Market Share (2011-2016)
Table GE Healthcare (UK) Basic Information List
Table GE Healthcare (UK) Recombinant Antibody Sales, Revenue, Price and Gross Margin (2011-2016)
Table GE Healthcare (UK) Recombinant Antibody Sales Market Share (2011-2016)
Table Lonza Biologics Ltd. (Switzerland) Basic Information List
Table Lonza Biologics Ltd. (Switzerland) Recombinant Antibody Sales, Revenue, Price and Gross Margin (2011-2016)
Table Lonza Biologics Ltd. (Switzerland) Recombinant Antibody Sales Market Share (2011-2016)
Table Merck KGaA (Germany) Basic Information List
Table Merck KGaA (Germany) Recombinant Antibody Sales, Revenue, Price and Gross Margin (2011-2016)
Table Merck KGaA (Germany) Recombinant Antibody Sales Market Share (2011-2016)
Table Meridian Life Science, Inc. (US) Basic Information List
Table Meridian Life Science, Inc. (US) Recombinant Antibody Sales, Revenue, Price and Gross Margin (2011-2016)
Table Meridian Life Science, Inc. (US) Recombinant Antibody Sales Market Share (2011-2016)
Table PerkinElmer, Inc. (US) Basic Information List
Table PerkinElmer, Inc. (US) Recombinant Antibody Sales, Revenue, Price and Gross Margin (2011-2016)
Table PerkinElmer, Inc. (US) Recombinant Antibody Sales Market Share (2011-2016)
Table Promega Corporation (US) Basic Information List
Table Promega Corporation (US) Recombinant Antibody Sales, Revenue, Price and Gross Margin (2011-2016)
Table Promega Corporation (US) Recombinant Antibody Sales Market Share (2011-2016)
Table Qiagen N.V. (Netherlands) Basic Information List
Table Qiagen N.V. (Netherlands) Recombinant Antibody Sales, Revenue, Price and Gross Margin (2011-2016)
Table Qiagen N.V. (Netherlands) Recombinant Antibody Sales Market Share (2011-2016)
Table R&D Systems (US) Basic Information List
Table R&D Systems (US) Recombinant Antibody Sales, Revenue, Price and Gross Margin (2011-2016)
Table R&D Systems (US) Recombinant Antibody Sales Market Share (2011-2016)
Table SDIX, LLC (US) Basic Information List
Table SDIX, LLC (US) Recombinant Antibody Sales, Revenue, Price and Gross Margin (2011-2016)
Table SDIX, LLC (US) Recombinant Antibody Sales Market Share (2011-2016)
Table Shimadzu Corporation (Japan) Basic Information List
Table Shimadzu Corporation (Japan) Recombinant Antibody Sales, Revenue, Price and Gross Margin (2011-2016)
Table Shimadzu Corporation (Japan) Recombinant Antibody Sales Market Share (2011-2016)
Table Takara Bio, Inc. (Japan) Basic Information List
Table Takara Bio, Inc. (Japan) Recombinant Antibody Sales, Revenue, Price and Gross Margin (2011-2016)
Table Takara Bio, Inc. (Japan) Recombinant Antibody Sales Market Share (2011-2016)
Table Thermo Fisher Scientific Inc. (US) Basic Information List
Table Thermo Fisher Scientific Inc. (US) Recombinant Antibody Sales, Revenue, Price and Gross Margin (2011-2016)
Table Thermo Fisher Scientific Inc. (US) Recombinant Antibody Sales Market Share (2011-2016)
Table Wako Pure Chemical Industries Ltd. (Japan) Basic Information List
Table Wako Pure Chemical Industries Ltd. (Japan) Recombinant Antibody Sales, Revenue, Price and Gross Margin (2011-2016)
Table Wako Pure Chemical Industries Ltd. (Japan) Recombinant Antibody Sales Market Share (2011-2016)
Table Waters Corp. (US) Basic Information List
Table Waters Corp. (US) Recombinant Antibody Sales, Revenue, Price and Gross Margin (2011-2016)
Table Waters Corp. (US) Recombinant Antibody Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Recombinant Antibody
Figure Manufacturing Process Analysis of Recombinant Antibody
Figure Recombinant Antibody Industrial Chain Analysis
Table Raw Materials Sources of Recombinant Antibody Major Manufacturers in 2015
Table Major Buyers of Recombinant Antibody
Table Distributors/Traders List
Figure USA Recombinant Antibody Production and Growth Rate Forecast (2016-2021)
Figure USA Recombinant Antibody Revenue and Growth Rate Forecast (2016-2021)
Table USA Recombinant Antibody Production Forecast by Type (2016-2021)
Table USA Recombinant Antibody Consumption Forecast by Application (2016-2021)
Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...
Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...
The pharmaceutical agents that are administered to treat, diagnose, and prevent life-threatening diseases (rare diseases) are known as orphan drugs. The global orphan drugs market accounted for $106 billion in 2015, and is anticipated to reach $169 billio...